Nuvation Bio IncNYSE:NUVB
- LAST PRICE3.3200
- TODAY'S CHANGE (%)-0.0900 (-2.6393%)
- Bid / Lots3.2500/ 2
- Ask / Lots3.3700/ 10
- Open / Previous Close3.4100 / 3.4100
- Day Range
- 52 Week Range
- Volume819,080
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NUVB |
|---|---|---|
| 09:32 ET | 28783 | 3.41 |
| 09:34 ET | 600 | 3.36 |
| 09:38 ET | 3800 | 3.375 |
| 09:39 ET | 600 | 3.36 |
| 09:41 ET | 15661 | 3.38 |
| 09:43 ET | 3100 | 3.38 |
| 09:45 ET | 200 | 3.395 |
| 09:48 ET | 600 | 3.42 |
| 09:50 ET | 3363 | 3.425 |
| 09:52 ET | 900 | 3.435 |
| 09:54 ET | 2611 | 3.45 |
| 09:56 ET | 425 | 3.446 |
| 09:57 ET | 200 | 3.45 |
| 09:59 ET | 2390 | 3.435 |
| 10:01 ET | 1253 | 3.45 |
| 10:03 ET | 8064 | 3.455 |
| 10:06 ET | 1826 | 3.455 |
| 10:08 ET | 6978 | 3.435 |
| 10:10 ET | 3164 | 3.418 |
| 10:12 ET | 1177 | 3.425 |
| 10:14 ET | 2131 | 3.431 |
| 10:15 ET | 200 | 3.44 |
| 10:17 ET | 5128 | 3.415 |
| 10:19 ET | 700 | 3.425 |
| 10:21 ET | 1311 | 3.425 |
| 10:24 ET | 796 | 3.44 |
| 10:26 ET | 500 | 3.445 |
| 10:28 ET | 14489 | 3.39 |
| 10:30 ET | 62044 | 3.375 |
| 10:32 ET | 2116 | 3.381 |
| 10:33 ET | 427 | 3.385 |
| 10:35 ET | 300 | 3.39 |
| 10:37 ET | 150 | 3.3861 |
| 10:39 ET | 700 | 3.39 |
| 10:42 ET | 1390 | 3.385 |
| 10:44 ET | 1285 | 3.39 |
| 10:46 ET | 25754 | 3.365 |
| 10:48 ET | 1004 | 3.3612 |
| 10:50 ET | 2327 | 3.365 |
| 10:51 ET | 900 | 3.365 |
| 10:53 ET | 100 | 3.37 |
| 10:55 ET | 600 | 3.37 |
| 10:57 ET | 4974 | 3.365 |
| 11:00 ET | 500 | 3.365 |
| 11:02 ET | 1682 | 3.36 |
| 11:04 ET | 1500 | 3.355 |
| 11:06 ET | 1400 | 3.355 |
| 11:08 ET | 4166 | 3.3675 |
| 11:09 ET | 1049 | 3.365 |
| 11:11 ET | 700 | 3.365 |
| 11:13 ET | 700 | 3.37 |
| 11:15 ET | 4291 | 3.355 |
| 11:18 ET | 700 | 3.355 |
| 11:20 ET | 300 | 3.355 |
| 11:22 ET | 1570 | 3.355 |
| 11:24 ET | 943 | 3.355 |
| 11:26 ET | 10032 | 3.355 |
| 11:27 ET | 1830 | 3.345 |
| 11:29 ET | 700 | 3.345 |
| 11:31 ET | 1293 | 3.345 |
| 11:33 ET | 3098 | 3.335 |
| 11:36 ET | 700 | 3.34 |
| 11:38 ET | 300 | 3.34 |
| 11:40 ET | 200 | 3.335 |
| 11:42 ET | 325 | 3.335 |
| 11:44 ET | 443 | 3.335 |
| 11:45 ET | 700 | 3.335 |
| 11:47 ET | 994 | 3.335 |
| 11:49 ET | 3496 | 3.325 |
| 11:51 ET | 2676 | 3.345 |
| 11:56 ET | 397 | 3.345 |
| 11:58 ET | 200 | 3.35 |
| 12:00 ET | 100 | 3.35 |
| 12:02 ET | 3949 | 3.355 |
| 12:03 ET | 861 | 3.355 |
| 12:05 ET | 858 | 3.355 |
| 12:07 ET | 758 | 3.355 |
| 12:09 ET | 9717 | 3.375 |
| 12:12 ET | 300 | 3.38 |
| 12:14 ET | 1505 | 3.375 |
| 12:16 ET | 200 | 3.375 |
| 12:18 ET | 400 | 3.375 |
| 12:20 ET | 100 | 3.375 |
| 12:21 ET | 4764 | 3.39 |
| 12:25 ET | 400 | 3.39 |
| 12:27 ET | 300 | 3.39 |
| 12:30 ET | 300 | 3.39 |
| 12:32 ET | 1678 | 3.39 |
| 12:34 ET | 400 | 3.39 |
| 12:36 ET | 3238 | 3.4 |
| 12:38 ET | 200 | 3.4 |
| 12:39 ET | 1924 | 3.4 |
| 12:41 ET | 400 | 3.4 |
| 12:43 ET | 5556 | 3.39 |
| 12:45 ET | 4024 | 3.375 |
| 12:48 ET | 1400 | 3.38 |
| 12:52 ET | 1722 | 3.39 |
| 12:54 ET | 100 | 3.4 |
| 12:56 ET | 8951 | 3.3826 |
| 12:59 ET | 100 | 3.385 |
| 01:01 ET | 100 | 3.39 |
| 01:06 ET | 7125 | 3.37 |
| 01:08 ET | 100 | 3.37 |
| 01:10 ET | 3298 | 3.375 |
| 01:12 ET | 100 | 3.38 |
| 01:15 ET | 400 | 3.375 |
| 01:17 ET | 250 | 3.3791 |
| 01:19 ET | 300 | 3.375 |
| 01:21 ET | 200 | 3.375 |
| 01:24 ET | 804 | 3.375 |
| 01:26 ET | 6514 | 3.39 |
| 01:28 ET | 200 | 3.39 |
| 01:30 ET | 100 | 3.39 |
| 01:32 ET | 3612 | 3.4 |
| 01:33 ET | 7431 | 3.385 |
| 01:35 ET | 2149 | 3.385 |
| 01:37 ET | 6625 | 3.385 |
| 01:39 ET | 2064 | 3.385 |
| 01:42 ET | 900 | 3.385 |
| 01:44 ET | 100 | 3.39 |
| 01:46 ET | 100 | 3.385 |
| 01:48 ET | 1498 | 3.385 |
| 01:50 ET | 12371 | 3.37 |
| 01:53 ET | 2240 | 3.365 |
| 01:55 ET | 100 | 3.365 |
| 01:57 ET | 300 | 3.365 |
| 02:00 ET | 200 | 3.365 |
| 02:02 ET | 400 | 3.365 |
| 02:04 ET | 6839 | 3.345 |
| 02:08 ET | 100 | 3.34 |
| 02:09 ET | 10952 | 3.355 |
| 02:13 ET | 16024 | 3.355 |
| 02:15 ET | 2206 | 3.34 |
| 02:20 ET | 2132 | 3.3385 |
| 02:22 ET | 2251 | 3.325 |
| 02:24 ET | 1500 | 3.315 |
| 02:26 ET | 300 | 3.32 |
| 02:27 ET | 400 | 3.315 |
| 02:29 ET | 300 | 3.315 |
| 02:31 ET | 600 | 3.315 |
| 02:33 ET | 4734 | 3.3009 |
| 02:36 ET | 100 | 3.3 |
| 02:38 ET | 3258 | 3.29 |
| 02:40 ET | 600 | 3.29 |
| 02:42 ET | 5485 | 3.305 |
| 02:44 ET | 200 | 3.3 |
| 02:45 ET | 9038 | 3.305 |
| 02:49 ET | 200 | 3.31 |
| 02:51 ET | 1538 | 3.305 |
| 02:54 ET | 600 | 3.305 |
| 02:56 ET | 400 | 3.305 |
| 02:58 ET | 6991 | 3.31 |
| 03:00 ET | 4600 | 3.305 |
| 03:02 ET | 5853 | 3.31 |
| 03:03 ET | 600 | 3.3 |
| 03:05 ET | 10615 | 3.295 |
| 03:07 ET | 300 | 3.29 |
| 03:09 ET | 1118 | 3.29 |
| 03:12 ET | 9462 | 3.295 |
| 03:14 ET | 2671 | 3.29 |
| 03:16 ET | 600 | 3.29 |
| 03:18 ET | 471 | 3.295 |
| 03:20 ET | 300 | 3.29 |
| 03:21 ET | 1208 | 3.295 |
| 03:23 ET | 1710 | 3.295 |
| 03:25 ET | 700 | 3.295 |
| 03:27 ET | 1525 | 3.3 |
| 03:30 ET | 1601 | 3.295 |
| 03:32 ET | 1800 | 3.295 |
| 03:34 ET | 14317 | 3.31 |
| 03:36 ET | 1100 | 3.31 |
| 03:38 ET | 1810 | 3.305 |
| 03:39 ET | 1600 | 3.31 |
| 03:41 ET | 2450 | 3.31 |
| 03:43 ET | 2421 | 3.31 |
| 03:45 ET | 10732 | 3.295 |
| 03:48 ET | 1182 | 3.295 |
| 03:50 ET | 2500 | 3.29 |
| 03:52 ET | 12169 | 3.31 |
| 03:54 ET | 11391 | 3.32 |
| 03:56 ET | 9884 | 3.32 |
| 03:57 ET | 22993 | 3.31 |
| 03:59 ET | 33740 | 3.32 |
May 15, 2024
DJ Nuvation Bio Price Target Maintained With a $5.00/Share by Wedbush, from 9:52AM ET on Wednesday May 15, 2024 by Dow Jones
9:52AM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones
4:05PM ET on Tuesday May 14, 2024 by Dow JonesPress Release: Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones
4:05PM ET on Tuesday May 14, 2024 by Dow Jones
Apr 24, 2024
Apr 17, 2024
DJ Nuvation Bio Is Maintained at Outperform by RBC Capital, from 11:05AM ET on Wednesday Apr 17, 2024 by Dow Jones
11:05AM ET on Wednesday Apr 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nuvation Bio Inc | 842.9M | -10.6x | --- |
Prime Medicine Inc | 845.0M | -3.3x | --- |
CARGO Therapeutics Inc | 840.1M | -8.6x | --- |
Zentalis Pharmaceuticals Inc | 849.3M | -3.6x | --- |
ProKidney Corp | 878.1M | -7.2x | --- |
ARS Pharmaceuticals Inc | 881.7M | -17.4x | --- |
Company Information
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Contact Information
- Headquarters
- 357 Tehama Street, Floor 3SAN FRANCISCO, CA, United States 94103
- Phone
- 415-754-3517
- Fax
- 302-636-5454
Executives
- Independent Chair of the Board
- Daniel Welch
- President, Chief Executive Officer, Founder, Director
- David Hung
- Principal Accounting Officer, Principal Financial Officer
- Moses Makunje
- Chief People Officer
- Stacy Markel
- Chief Scientific Officer
- Gary Hattersley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $842.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 247.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.45 |
EPS | $-0.31 |
Book Value | $2.76 |
P/E Ratio | -10.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
